150 related articles for article (PubMed ID: 8814718)
1. The usefulness of cardio-vascular visualization in the localization of mediastinal pheochromocytomas with I-131-MIBG.
Başoğlu T; Olivier P; Arsena T; Marie PY; Schlienger JL; Karcher G; Bertrand A
Ann Nucl Med; 1996 Feb; 10(1):135-8. PubMed ID: 8814718
[TBL] [Abstract][Full Text] [Related]
2. Use of 131I-MIBG scintigraphy in the evaluation of suspected pheochromocytoma.
Swensen SJ; Brown ML; Sheps SG; Sizemore GW; Gharib H; Grant CS; van Heerden JA
Mayo Clin Proc; 1985 May; 60(5):299-304. PubMed ID: 3990377
[TBL] [Abstract][Full Text] [Related]
3. Thallium-201 scintigraphy in the diagnosis of pheochromocytoma.
Wenisch HJ; Maul FD; Happ J; Schumm PM; Bittner G; Wanner U; Hör G; Encke A
Cardiology; 1985; 72 Suppl 1():150-2. PubMed ID: 4053122
[TBL] [Abstract][Full Text] [Related]
4. 99mTc-HYNIC-TOC scintigraphy is superior to 131I-MIBG imaging in the evaluation of extraadrenal pheochromocytoma.
Chen L; Li F; Zhuang H; Jing H; Du Y; Zeng Z
J Nucl Med; 2009 Mar; 50(3):397-400. PubMed ID: 19223405
[TBL] [Abstract][Full Text] [Related]
5. Comparison of radiolabeled octreotide and meta-iodobenzylguanidine (MIBG) scintigraphy in malignant pheochromocytoma.
Tenenbaum F; Lumbroso J; Schlumberger M; Mure A; Plouin PF; Caillou B; Parmentier C
J Nucl Med; 1995 Jan; 36(1):1-6. PubMed ID: 7799058
[TBL] [Abstract][Full Text] [Related]
6. [Clinical evaluation of 131I-MIBG (meta-iodobenzylguanidine) imaging in suspected pheochromocytoma].
Nakabeppu Y; Nakajo M; Iwashita S; Yonekura R; Yoshimura H; Shimabukuro K; Shinohara S; Sakata H
Kaku Igaku; 1989 Nov; 26(11):1445-51. PubMed ID: 2615031
[No Abstract] [Full Text] [Related]
7. Intraoperative localization of malignant pheochromocytoma by 123-I-metaiodobenzylguanidine single probe measurement.
Lehnert H; Weber P; Nägele-Wöhrle B; von Bülow M; Eissner D; Schweden F; Junginger T; Schrezenmeir J; Krause U; Beyer J
Klin Wochenschr; 1988 Jan; 66(2):61-4. PubMed ID: 3347006
[TBL] [Abstract][Full Text] [Related]
8. The diagnosis of nonfunctioning pheochromocytoma. The role of I-123 MIBG imaging.
Maurea S; Lastoria S; Cuocolo A; Celentano L; Salvatore M
Clin Nucl Med; 1995 Jan; 20(1):22-4. PubMed ID: 7895430
[TBL] [Abstract][Full Text] [Related]
9. Extra-adrenal and metastatic pheochromocytoma: the role of 131I meta-iodobenzylguanidine (131I MIBG) in localization and management.
Thompson NW; Allo MD; Shapiro B; Sisson JC; Beierwaltes W
World J Surg; 1984 Aug; 8(4):605-11. PubMed ID: 6148810
[No Abstract] [Full Text] [Related]
10. Pheochromocytoma: diagnosis by scintigraphy using iodine 131 metaiodobenzylguanidine.
Campeau RJ; Garcia OM; Correa OA; Rege AB
South Med J; 1991 Oct; 84(10):1221-30. PubMed ID: 1925724
[TBL] [Abstract][Full Text] [Related]
11. Early diagnosis of and surgical strategy for adrenal medullary disease in MEN II gene carriers.
Jansson S; Tisell LE; Fjälling M; Lindberg S; Jacobsson L; Zachrisson BF
Surgery; 1988 Jan; 103(1):11-8. PubMed ID: 2892276
[TBL] [Abstract][Full Text] [Related]
12. Locating pheochromocytomas by scintigraphy using 131I-metaiodobenzylguanidine.
Sisson JC; Shapiro B; Beierwaltes WH; Copp JE
CA Cancer J Clin; 1984; 34(2):86-92. PubMed ID: 6423224
[TBL] [Abstract][Full Text] [Related]
13. 131I-MIBG--a new agent in diagnosis and treatment of pheochromocytoma.
Shapiro B; Sisson JC; Eyre P; Copp JE; Dmuchowski C; Beierwaltes WH
Cardiology; 1985; 72 Suppl 1():137-42. PubMed ID: 4053121
[TBL] [Abstract][Full Text] [Related]
14. [Diagnosis of pheochromocytoma by 131I-MIBG scintigraphy].
Miyanaga N; Hattori K; Shiraiwa H; Hinotsu S; Nemoto R; Koiso K; Takeda T; Ishikawa N
Hinyokika Kiyo; 1990 Feb; 36(2):105-8. PubMed ID: 2343801
[TBL] [Abstract][Full Text] [Related]
15. Intraoperative radionuclear 125I-labeled metaiodobenzylguanidine scanning of pheochromocytomas and metastases.
Proye CA; Carnaille BM; Flament JB; Hossein-Foucher CA; Lecouffe PP; Marchandise XM; Lennquist S
Surgery; 1992 Jun; 111(6):634-9. PubMed ID: 1595059
[TBL] [Abstract][Full Text] [Related]
16. Pheochromocytoma and the normal adrenal medulla: improved visualization with I-123 MIBG scintigraphy.
Lynn MD; Shapiro B; Sisson JC; Beierwaltes WH; Meyers LJ; Ackerman R; Mangner TJ
Radiology; 1985 Jun; 155(3):789-92. PubMed ID: 4001380
[TBL] [Abstract][Full Text] [Related]
17. Portrayal of pheochromocytoma and normal human adrenal medulla by m-[123I]iodobenzylguanidine: concise communication.
Lynn MD; Shapiro B; Sisson JC; Swanson DP; Mangner TJ; Wieland DM; Meyers LJ; Glowniak JV; Beierwaltes WH
J Nucl Med; 1984 Apr; 25(4):436-40. PubMed ID: 6544815
[TBL] [Abstract][Full Text] [Related]
18. Semiquantitative 123I-Metaiodobenzylguanidine Scintigraphy to Distinguish Pheochromocytoma and Paraganglioma from Physiologic Adrenal Uptake and Its Correlation with Genotype-Dependent Expression of Catecholamine Transporters.
van Berkel A; Rao JU; Lenders JW; Pellegata NS; Kusters B; Piscaer I; Hermus AR; Plantinga TS; Langenhuijsen JF; Vriens D; Janssen MJ; Gotthardt M; Timmers HJ
J Nucl Med; 2015 Jun; 56(6):839-46. PubMed ID: 25883126
[TBL] [Abstract][Full Text] [Related]
19. Iodine-131 MIBG scintigraphy of the extremities in metastatic pheochromocytoma and neuroblastoma.
Shulkin BL; Shen SW; Sisson JC; Shapiro B
J Nucl Med; 1987 Mar; 28(3):315-8. PubMed ID: 3102702
[TBL] [Abstract][Full Text] [Related]
20. Low-dose (123)I-metaiodobenzylguanidine diagnostic scan is inferior to (131)I-metaiodobenzylguanidine posttreatment scan in detection of malignant pheochromocytoma and paraganglioma.
Kayano D; Taki J; Fukuoka M; Wakabayashi H; Inaki A; Nakamura A; Kinuya S
Nucl Med Commun; 2011 Oct; 32(10):941-6. PubMed ID: 21876405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]